The current literature also links DNMT3A and isocitrate dehydrogenase 1 enzyme (IDH1) to both adult and paediatric AML, which does suggest that their targeting could prove an effective approach across a broad range of age groups. This evidence concerns the gene IDH1 and acute myeloid leukemia.